Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alzheimer's disease
Alzheimer's disease
BioXcel to trial Apple Watch-drug combination to prevent Alzheimer’s agitation episodes
BioSpace
Thu, 09/19/19 - 12:33 pm
BioXcel
wearables
Apple Watch
Alzheimer's disease
BXCL501
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Biogen
Eisai
Alzheimer's disease
BACE inhibitors
elenbecestat
aducanumab
Investors lost big as Alzheimer’s R&D went over the cliff in 2019. Will they ever come back?
Endpoints
Wed, 09/11/19 - 11:39 pm
Alzheimer's disease
R&D
Biogen
Neurotrope
Citing phase 2 figures, Axon looks for big pharma investment for Alzheimer’s vaccine
Pharmaforum
Mon, 09/9/19 - 08:10 pm
Alzheimer's disease
drug development
vaccines
Axon
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
Fierce Biotech
Sat, 09/7/19 - 06:28 pm
psychedelic drugs
Johns Hopkins
drug development
Alzheimer's disease
addiction
D&D bags $137M to fund midphase Alzheimer's, Parkinson's trials
Fierce Biotech
Wed, 08/14/19 - 11:03 am
D&D Pharmatech
neurodegenerative disease
Alzheimer's disease
Parkinson's Disease
Is a Low-Cost Blood Test for Alzheimer's on the Horizon?
BioSpace
Sat, 08/3/19 - 02:18 pm
diagnostics
Alzheimer's disease
Washington University
Scientists close in on blood test for Alzheimer’s
Stat
Mon, 07/15/19 - 07:09 pm
Alzheimer's disease
dementia
diagnostics
Neon and Neurotrope await signs of proof of concept
EP Vantage
Sat, 07/13/19 - 11:19 am
Neon Therapeutics
neoantigens
Neurotrope BioScience
Alzheimer's disease
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Alzheimer's disease
BACE inhibitors
Merck
Eli Lilly
AstraZeneca
Amgen
Novartis
Biogen Eisai
Tiaki hires Bruhn as CEO for Alzheimer's drug discovery push
Fierce Biotech
Thu, 07/11/19 - 10:59 pm
Tiaki Therapeutics
Suzanne Bruhn
Alzheimer's disease
Dementia tied to hormone-blocking prostate cancer treatment
Yahoo/AP
Sun, 07/7/19 - 10:25 pm
Alzheimer's disease
prostate cancer
New Markers For Alzheimer's Disease Could Aid Diagnosis And Speed Up Drug Development
NPR
Fri, 07/5/19 - 01:55 pm
Alzheimer's disease
biomarkers
drug develoment
R&D
diagnostics
Denovo Biopharma Acquires Global Rights to Experimental Alzheimer’s Drug
BioSpace
Wed, 06/19/19 - 11:02 pm
DeNovo
Alzheimer's disease
ORM-12741
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
CP Wire
Mon, 06/17/19 - 12:22 pm
Karuna Therapeutics
IPOs
schizophrenia
Alzheimer's disease
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
Mon, 06/17/19 - 09:24 am
Karuna
schizophrenia
Alzheimer's disease
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures
Investors Business Daily
Sat, 06/15/19 - 05:44 pm
Alzheimer's disease
drug development
Biogen
Eisai
Research Roundup: A New Protein Linked to Alzheimer’s and Other Highlights
BioSpace
Fri, 06/14/19 - 06:31 pm
R&D
Alzheimer's disease
genetic translation
A Missed Alzheimer’s Opportunity? Not So Much
In the Pipeline
Thu, 06/6/19 - 01:17 pm
Pfizer
Enbrel
Alzheimer's disease
social media
clinical trials
journalism
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?
Washington Post, DC
Wed, 06/5/19 - 01:00 pm
Pfizer
Enbrel
Alzheimer's disease
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »